Risk of skeletal-related events (SREs) in patients with prostate cancer (PC) and newly diagnosed metastases to bone.

被引：0
|
作者：
Glass, Andrew
Lamerato, Lois
Edelsberg, John
Richert-Boe, Kathryn E.
Taneja, Charu
Wolff, Greg G.
Czapski, Natalie
Chung, Karen
Richhariya, Akshara
Oster, Gerry
机构：
[1] Kaiser Permanente Northwest, Portland, OR USA
[2] Henry Ford Hlth Syst, Detroit, MI USA
[3] Policy Anal Inc, Brookline, MA USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15197
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Risk of skeletal-related events (SREs) in patients with breast cancer (BC) and newly diagnosed metastases to bone.
    Taneja, Charu
    Lamerato, Lois
    Glass, Andrew
    Richert-Boe, Kathryn E.
    Edelsberg, John
    Wolff, Greg G.
    Czapski, Natalie
    Chung, Karen
    Richhariya, Akshara
    Oster, Gerry
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [2] Risk of skeletal-related events (SREs) in patients with breast cancer (BC) and newly diagnosed metastases to bone.
    Taneja, Charu
    Lamerato, Lois
    Glass, Andrew
    Richert-Boe, Kathryn E.
    Edelsberg, John
    Wolff, Greg G.
    Czapski, Natalie
    Chung, Karen
    Richhariya, Akshara
    Oster, Gerry
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Intravenous and oral ibandronate reduce the risk of skeletal-related events (SREs) in patients with breast cancer and bone metastases
    Tripathy, D.
    Body, J. -J.
    Die, I. J.
    Bergstrom, B.
    EJC SUPPLEMENTS, 2004, 2 (03): : 138 - 138
  • [4] Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting
    Trinkaus, Mateya
    Simmons, Christine
    Myers, Jeff
    Dranatisaris, George
    Clemons, Mark
    SUPPORTIVE CARE IN CANCER, 2010, 18 (02) : 197 - 203
  • [5] Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting
    Mateya Trinkaus
    Christine Simmons
    Jeff Myers
    George Dranatisaris
    Mark Clemons
    Supportive Care in Cancer, 2010, 18 : 197 - 203
  • [6] Incidence of skeletal-related events (SREs) among prostate cancer patients.
    Yood, Marianne Ulcickas
    Zyczynski, Teresa Maria
    Wells, Karen
    Casso, Deborah
    Gutierrez, Benjamin
    Woodcroft, Kimberley J.
    Cheng, Shinta
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Risk of skeletal-related events (SREs) following initial diagnosis of bony metastases in breast, lung, and prostate cancer
    Lamerato, Lois
    Glass, Andrew
    Wolff, Greg G.
    Richert-Boe, Kathryn E.
    Taneja, Charu
    Edelsberg, John
    Czapski, Natalie
    Chung, Karen
    Richhariya, Akshara
    Oster, Gerry
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Intravenous (i.v.) and oral ibandronate reduce the risk of skeletal-related events (SREs) in patients with breast cancer and bone metastases
    Tripathy, D
    Bergström, B
    BONE, 2005, 36 : S211 - S212
  • [9] Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases
    Hagiwara, M.
    Delea, T. E.
    Saville, M. W.
    Chung, K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (01) : 23 - 27
  • [10] Bone Pain, Skeletal-Related Events and Opioid Analgesic Use in Prostate Cancer Patients with Bone Metastases
    Valderrama, Adriana
    Eapen, Sara
    Hennessey, Kelly A.
    Jones, Casey
    Wen, Lonnie
    Germino, Joseph
    Duh, Mei S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 473 - 473
12345